Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 123 Radiotherapy 47 Bevacizumab 46 Lomustine 25 Radiation 20 Nivolumab 17 Irinotecan 16 Carboplatin 16 Cyclophosphamide 14 Granulocyte-Macrophage Colony-Stimulating Factor 13 pembrolizumab 11 dabrafenib 10 Trastuzumab 10 Surgical Procedures, Operative 10 Capecitabine 10 paclitaxel-Angiopep-2 conjugate 8 TIC10 compound 8 Paclitaxel 8 Gemcitabine 8 Carmustine 8 trametinib 7 Topotecan 7 IL13-PE38 7 Everolimus 7 Drug Therapy 7 Aminolevulinic Acid 7 AZD 6244 7 3-Iodobenzylguanidine 7 fludarabine 6 enzastaurin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × cositecan × CNS × Clear all

NCT00062478 2020-03-12

Study of Karenitecin (BNP1350) in Patients With Brain Tumors

BioNumerik Pharmaceuticals, Inc.

Phase 2 Completed

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡